The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
NCRI 2016 | Occurence of APOBEC mutagenesis in human cancers
Reuben Harris, PhD of University of Minnesota, Minneapolis, MN discusses APOBEC mutagenesis, which occurs in almost half of human cancers. In some cancer types almost all mutations are attributable to this source of mutation. Other cancer types may be less affected, but Dr Harris points out that this knowledge could be used moving forward when new therapies are designed. Recorded at the 2016 National Cancer Research Institute (NCRI) Conference in Liverpool, UK.
